Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

37 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Treating multidrug-resistant tuberculosis in Tomsk, Russia: developing programs that address the linkage between poverty and disease.
Keshavjee S, Gelmanova IY, Pasechnikov AD, Mishustin SP, Andreev YG, Yedilbayev A, Furin JJ, Mukherjee JS, Rich ML, Nardell EA, Farmer PE, Kim JY, Shin SS. Keshavjee S, et al. Among authors: yedilbayev a. Ann N Y Acad Sci. 2008;1136:1-11. doi: 10.1196/annals.1425.009. Epub 2007 Oct 22. Ann N Y Acad Sci. 2008. PMID: 17954675
National policies for delivering tuberculosis, HIV and hepatitis B and C virus infection services for refugees and migrants among Member States of the WHO European Region.
Baggaley RF, Nazareth J, Divall P, Pan D, Martin CA, Volik M, Seguy NS, Yedilbayev A, Reinap M, Vovc E, Mozalevskis A, Dadu A, Waagensen E, Kruja K, Sy TR, Nellums L, Pareek M. Baggaley RF, et al. Among authors: yedilbayev a. J Travel Med. 2023 Feb 18;30(1):taac136. doi: 10.1093/jtm/taac136. J Travel Med. 2023. PMID: 36426801 Free PMC article. Review.
Treatment outcomes in an integrated civilian and prison MDR-TB treatment program in Russia.
Shin SS, Pasechnikov AD, Gelmanova IY, Peremitin GG, Strelis AK, Mishustin S, Barnashov A, Karpeichik Y, Andreev YG, Golubchikova VT, Tonkel TP, Yanova GV, Nikiforov M, Yedilbayev A, Mukherjee JS, Furin JJ, Barry DJ, Farmer PE, Rich ML, Keshavjee S. Shin SS, et al. Among authors: yedilbayev a. Int J Tuberc Lung Dis. 2006 Apr;10(4):402-8. Int J Tuberc Lung Dis. 2006. PMID: 16602404
Adverse reactions among patients being treated for MDR-TB in Tomsk, Russia.
Shin SS, Pasechnikov AD, Gelmanova IY, Peremitin GG, Strelis AK, Mishustin S, Barnashov A, Karpeichik Y, Andreev YG, Golubchikova VT, Tonkel TP, Yanova GV, Yedilbayev A, Rich ML, Mukherjee JS, Furin JJ, Atwood S, Farmer PE, Keshavjee S. Shin SS, et al. Among authors: yedilbayev a. Int J Tuberc Lung Dis. 2007 Dec;11(12):1314-20. Int J Tuberc Lung Dis. 2007. PMID: 18034952
Improving outcomes for multidrug-resistant tuberculosis: aggressive regimens prevent treatment failure and death.
Velásquez GE, Becerra MC, Gelmanova IY, Pasechnikov AD, Yedilbayev A, Shin SS, Andreev YG, Yanova G, Atwood SS, Mitnick CD, Franke MF, Rich ML, Keshavjee S. Velásquez GE, et al. Among authors: yedilbayev a. Clin Infect Dis. 2014 Jul 1;59(1):9-15. doi: 10.1093/cid/ciu209. Epub 2014 Apr 11. Clin Infect Dis. 2014. PMID: 24729493 Free PMC article.
Aggressive Regimens Reduce Risk of Recurrence After Successful Treatment of MDR-TB.
Ahmad Khan F, Gelmanova IY, Franke MF, Atwood S, Zemlyanaya NA, Unakova IA, Andreev YG, Berezina VI, Pavlova VE, Shin SS, Yedilbayev AB, Becerra MC, Keshavjee S. Ahmad Khan F, et al. Among authors: yedilbayev ab. Clin Infect Dis. 2016 Jul 15;63(2):214-20. doi: 10.1093/cid/ciw276. Epub 2016 May 8. Clin Infect Dis. 2016. PMID: 27161772
Culture conversion at six months in patients receiving bedaquiline- and delamanid-containing regimens for the treatment of multidrug-resistant tuberculosis.
Maretbayeva SM, Rakisheva AS, Adenov MM, Yeraliyeva LT, Algozhin YZ, Stambekova AT, Berikova EA, Yedilbayev A, Rich ML, Seung KJ, Issayeva AM. Maretbayeva SM, et al. Among authors: yedilbayev a. Int J Infect Dis. 2021 Dec;113 Suppl 1:S91-S95. doi: 10.1016/j.ijid.2021.03.075. Epub 2021 Apr 3. Int J Infect Dis. 2021. PMID: 33823277 Free article.
Safety and Effectiveness of 3 Novel All-Oral Shortened Regimens for Rifampicin- or Multidrug-Resistant Tuberculosis in Kazakhstan.
Rashitov M, Franke MF, Trevisi L, Bekbolatova G, Shalimova J, Eshmetov G, Bektasov S, LaHood A, Arlyapova N, Osso E, Yedilbayev A, Korotych O, Ciobanu A, Skrahina A, Mitnick CD, Seung KJ, Algozhin Y, Rich ML. Rashitov M, et al. Among authors: yedilbayev a. Clin Infect Dis. 2024 Oct 15;79(4):1046-1053. doi: 10.1093/cid/ciae305. Clin Infect Dis. 2024. PMID: 38833593 Free PMC article.
37 results